Please upgrade your browser.
Dr. Oleg Loran treats kidney cancer, but he doesn't have much to offer his patients. They have a 60% chance of surviving five years if the disease is caught early, but more than a third are diagnosed after the cancer is well advanced, when their chances of reaching the five-year mark drop as low as 11%.
Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancer
Although Renal Cell Cancer (RCC) is known to be immunogenic, clinical efficacy of various immunotherapeutic approaches remains unsatisfactory.
Dr. Davidson is testing a new approach to treatment of HHT. He's using the cancer drug Avastin in low doses in both injection and spray forms to stop the nosebleeds.
The story of the drug, which took 15 years to get from theory to therapy, shows why such medicines, which have limited periods of effectiveness, are so expensive that some governments resist paying for them.
Of the 305 patients who underwent NSS at our institute from October 2004 to July 2009, seven (2%) were found to have stage T3bNxMx RCC on final pathology. Their charts were reviewed to identify demographic, operative and pathology details of these patients, in addition to obtaining functional and oncological outcome data.
To determine whether primary extracorporeal high-intensity focused ultrasound (HIFU) is safe, feasible and effective for managing small renal tumours.
Stereotactic percutaneous cryoablation and laparoscopic renal cryoablation are effective treatments for selected patients with kidney cancer, according to the results of two studies published in the Journal of Urology.
In human RCC xenograft models, CEC levels showed promise as an adjuvant biomarker in evaluating disease burden. Results from correlating CEC levels with tumour variables such as tumour volume, weight and vascularity suggested that CEC levels were a better prognostic indicator during early phases of tumour growth.
A 63-year-old with history of renal cell carcinoma presents with a painful oral cavity lesion that has grown substantially in the past months and is associated with occasional bleeding.
|Powered by NeonCRM|